Omada Health, INC Form 4 insider transactions

Omada Health's Chief Financial Officer, Steven L. Cook, reported a sale of 4,493 shares of common stock on June 1, 2026.

Omada Health Chief Accounting Officer Craig Gracey reported a sale of 385 shares of common stock on June 1, 2026, for $18.38 per share.

Omada Health, Inc. reports a significant stock sale by President Wei-Li Shao.

Sean P. Duffy, CEO and Director of Omada Health, Inc., reported a transaction involving the sale of 9,884 shares of common stock.

Omada Health President Wei-Li Shao sold 2,829 shares of common stock for approximately $36,000 under a pre-arranged 10b5-1 trading plan.

Jeryl L. Hilleman, a Director at Omada Health, Inc., acquired 1,544 shares of common stock on April 5, 2026, as part of the company's Non-Employee Director Compensation Program.

Omada Health Director Jonathan D. Root acquired 882 shares of common stock through restricted stock units granted under the company's Non-Employee Director Compensation Program.

Omada Health Director Julie D. Klapstein acquired 698 shares of common stock through restricted stock units granted under the company's Non-Employee Director Compensation Program.

Omada Health Director Trevor Fetter has reported transactions involving restricted stock units and common stock, including the acquisition of RSUs in lieu of fees and a transfer of shares to a family trust.

Omada Health's Chief Financial Officer, Steven L. Cook, sold 1,884 shares of common stock for $13.94 per share under a pre-arranged 10b5-1 trading plan.

Omada Health's Chief Accounting Officer, Craig Gracey, was granted 16,470 restricted stock units, vesting quarterly over four years starting March 1, 2026.

Omada Health's Chief Financial Officer, Steven L. Cook, was granted 147,058 restricted stock units, vesting quarterly over four years.

Omada Health's President, Wei-Li Shao, was granted 264,705 restricted stock units, aligning executive incentives with long-term company performance.

Omada Health CEO Sean P. Duffy reported the acquisition of 323,529 restricted stock units and updated his beneficial ownership.

Omada Health CEO Sean P. Duffy exercised expiring stock options and subsequently sold a portion of the acquired common stock in January 2026.

Omada Health's Director, Jonathan D. Root, was granted 915 restricted stock units as part of the company's non-employee director compensation program.

Omada Health Director Trevor Fetter reported the acquisition of 991 common shares through restricted stock units as part of his compensation.

Omada Health, Inc. Director Jeryl L. Hilleman received a grant of 1,601 restricted stock units on January 5, 2026, as part of the company's non-employee director compensation program.

Omada Health President Wei-Li Shao sold 5,618 shares of common stock at a weighted average price of $16.1349 per share under a pre-arranged 10b5-1 trading plan.

Omada Health Director Jeryl L. Hilleman filed an amended Form 4 to correct an overstatement of 45 restricted stock units in a previous filing.

Omada Health's Chief Financial Officer, Steven L. Cook, sold 4,211 shares of common stock for $15.3657 per share under a pre-arranged 10b5-1 trading plan.

Omada Health CEO Sean P. Duffy sold 9,266 shares of common stock for $15.3657 per share under a pre-arranged 10b5-1 trading plan.

Omada Health's President, Wei-Li Shao, disposed of 1,843 common shares at $17.49 each to cover tax liabilities.

Omada Health CEO Sean P. Duffy disposed of 4,413 shares of common stock to cover tax withholding obligations at a price of $17.49 per share.

Omada Health's Chief Financial Officer, Steven L. Cook, disposed of 2,006 shares of common stock to cover tax withholding obligations.

Omada Health Director Jonathan D. Root reports an in-kind distribution of common stock from USVP X Funds, resulting in a change in his beneficial ownership.

Jonathan D. Root, a Director at Omada Health, Inc., acquired 657 restricted stock units as part of his compensation.

Omada Health, Inc. Director Trevor Fetter was granted 712 restricted stock units as part of the company's non-employee director compensation program.

Jeryl L. Hilleman, a director at Omada Health, Inc., acquired 1,126 restricted stock units as part of the company's non-employee director compensation program.

Omada Health's Chief Financial Officer, Steven L. Cook, disposed of 2,006 shares of common stock at $24.28 per share to cover tax withholding obligations.